Protection of human and murine hepatocytes against Fas-induced death by transferrin and iron

Apoptosis

Volumn 11, Issue 1, 2006, Pages 79-87

  Lesnikov, V A ^a   Abbasi, N ^a   Lesnikova, M P ^a   Lazaro, C A ^b   Campbell, J S ^b   Fausto, N ^b   Deeg, H J ^a,b  

^a Fred Hutchinson Cancer Research Center   (United States)

^b UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

Apoptosis; Cytoprotection; Fas; Hepatocytes; Iron; Transferrin

Indexed keywords

FAS ANTIGEN; IRON; IRON CHELATE; ISONIAZID DERIVATIVE; SALICYLALDEHYDE; TRANSFERRIN;

ANIMAL CELL; ARTICLE; CELL DEATH; CELL LINE; CELL PROTECTION; CELL SURVIVAL; FEMALE; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; LIVER CELL; LIVER FAILURE; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

ALDEHYDES; ANIMALS; ANTIBODIES, MONOCLONAL; ANTIGENS, CD95; APOPTOSIS; BASE SEQUENCE; BCL-X PROTEIN; BH3 INTERACTING DOMAIN DEATH AGONIST PROTEIN; CASPASE 9; CELL LINE; DACTINOMYCIN; DNA, COMPLEMENTARY; FEMALE; HEPATOCYTES; HUMANS; HYDRAZONES; IRON; IRON CHELATING AGENTS; MICE; MICE, INBRED BALB C; RNA, MESSENGER; SIGNAL TRANSDUCTION; TRANSFERRIN;

ANIMALIA; MURINAE;

EID: 31444443588     PISSN: 13608185     EISSN: 1573675X     Source Type: Journal    
DOI: 10.1007/s10495-005-3086-2     Document Type: Article

References (28)

1. Crichton RR. Proteins of iron storage and transport. (Review). Adv. Protein Chem. 1990; 40: 281-363.
2. de Jong G, van Dijk JP, van Eijk HG. The biology of transferrin. (Review). Clinica Chimica Acta 1990; 190: 1-46.
3. Ponka P, Beaumont C, Richardson DR. Function and regulation of transferrin and ferritin {Review}. Semi. Hematol. 1998; 35: 35-54.
4. Lesnikova M, Lesnikov V, Arrighi S, Kistler G, Pierpaoli W, Deeg HJ. Upregulation of interleukin-10 and inhibition of alloantigen responses by transferrin and transferrin-derived glycans. J. Hematoth. Stem Cell Res. 2000; 9: 381-392.
5. Lesnikov V, Lesnikova M, Deeg HJ. Pro-apoptotic and anti-apoptotic effects of transferrin and transferrin-derived glycans on hematopoietic cells and lymphocytes. Experim. Hematol. 2001; 29: 477-489.
6. Weinzimer SA, Gibson TB, Collett-Solberg PF, Khare A, Liu B, Cohen P. Transferrin is an insulin-like growth factor-binding protein-3 binding protein. J. Clin. Endocrinol. Metab. 2001; 86: 1806-1813.
7. Storch S, Kubler B, Honing S, et al. Transferrin binds insulin-like growth factors and affects binding properties of insulin-like growth factor binding protein-3. FEBS Letters 2001; 509: 395-398.
8. Fassl S, Leisser C, Huettenbrenner S, et al. Transferrin ensures survival of ovarian carcinoma cells when apoptosis is induced by TNFalpha, FasL, TRAIL, or Myc. Oncogene 2003; 22: 8343-8355.
9. Ogasawara J, Watanabe-Fukunaga R, Adachi M, et al. Lethal effect of the anti-Fas antibody in mice {published erratum appears in Nature 1993 Oct 7;365(6446):568}. Nature 1993; 364: 806-809.
10. Lesnikov VA, Lesnikova MP, Shulman HM, et al. Prevention of Fas-mediated hepatic failure by transferrin. Laborat. Invest. 2004; 84: 342-352.
11. Templeton DM, Liu Y. Genetic regulation of cell function in response to iron overload or chelation (Review). Biochim. Biophys. Acta 2003; 1619: 113-124.
12. van den Dobbelsteen DJ, Nobel CS, Schlegel J, Cotgreave IA, Orrenius S, Slater AF. Rapid and specific efflux of reduced glutathione during apoptosis induced by anti-Fas/APO-1 antibody. J. Biol. Chemis. 1996; 271: 15420-15427.
13. Domenicotti C, Marengo B, Nitti M, et al. A novel role of protein kinase C-delta in cell signaling triggered by glutathione depletion. Biochem. Pharmacol. 2003; 66: 1521-1526.
14. Pierpaoli W, Lesnikov VA, Lesnikova MP, Arrighi S, Bardotti A. Unresponsiveness to human leukocytes in immunosuppressed mice by combined donor-derived human transferrin and antigens. Trans. Immunol. 1996; 4: 301-308.
15. Hermes-Lima M, Ponka P, Schulman HM. The iron chelator pyridoxal isonicotinoyl hydrazone (PIH) and its analogues prevent damage to 2-deoxyribose mediated by ferric iron plus ascorbate. Biochim. Biophy. Acta 2000; 1523: 154-160.
16. Wu JC, Merlino G, Fausto N. Establishment and characterization of differentiated, nontransformed hepatocyte cell lines derived from mice transgenic for transforming growth factor alpha. Proc. Nat. Acad. Sci. USA 1994; 91: 674-678.
17. Arsura M, FitzGerald MJ, Fausto N, Sonenshein GE. Nuclear factor-kappaB/Rel blocks transforming growth factor beta1-induced apoptosis of murine hepatocyte cell lines. Cell Growth & Differentiation 1997; 8: 1049-1059.
18. Buss JL, Neuzil J, Gellert N, Weber C, Ponka P. Pyridoxal isonicotinoyl hydrazone analogs induce apoptosis in hematopoietic cells due to their iron-chelating properties. Biochem. Pharmacol. 2003; 65: 161-172.
19. Alcantara O, Javors M, Boldt DH. Induction of protein kinase C mRNA in cultured lymphoblastoid T cells by iron-transferrin but not by soluble iron. Blood 1991; 77: 1290-1297.
20. Vercammen D, Brouckaert G, Denecker G, et al. Dual signaling of the Fas receptor: Initiation of both apoptotic and necrotic cell death pathways. J. Experim. Med. 1998; 188: 919-930.
21. Wang X, Ryter SW, Dai C et al. Necrotic cell death in response to oxidant stress involves the activation of the apoptogenic caspase-8/bid pathway. J. Biol. Chem. 2003; 278: 29184-29191.
22. Quirk SM, Harman RM, Huber SC, Cowan RG. Responsiveness of mouse corpora luteal cells to Fas antigen (CD95)-mediated apoptosis. Biol. Reprod. 2000; 63: 49-56.
23. Ferris CD, Jaffrey SR, Sawa A et al. Haem oxygenase-1 prevents cell death by regulating cellular iron. Nature Cell Biol. 1999; 1: 152-157.
24. Kakhlon O, Cabantchik ZI. The labile iron pool: Characterization, measurement, and participation in cellular processes (Review). Free Radical Biology & Medicine 2002; 33: 1037-1046.
25. Susin SA, Lorenzo HK, Zamzami N et al. Molecular characterization of mitochondrial apoptosis-inducing factor. Nature 1999; 397: 441-446.
26. Kim S, Ponka P. Effects of interferon-gamma and lipopolysaccharide on macrophage iron metabolism are mediated by nitric oxide-induced degradation of iron regulatory protein 2. J. Biol. Chem. 2000; 275: 6220-6226.
27. Darnell G, Richardson DR. The potential of iron chelators of the pyridoxal isonicotinoyl hydrazone class as effective antiproliferative agents III: The effect of the ligands on molecular targets involved in proliferation. Blood 1999; 94: 781-792.
28. Dhungana S, Taboy CH, Zak O, Larvie M, Crumbliss AL, Aisen P. Redox properties of human transferrin bound to its receptor. Biochem. 2004; 43: 205-209.